MICROBOT MEDICAL INC (MBOT)
US59503A2042 - Common Stock
Taking everything into account, MBOT scores 2 out of 10 in our fundamental rating. MBOT was compared to 187 industry peers in the Health Care Equipment & Supplies industry. MBOT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. MBOT does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
In the past year MBOT has reported negative net income.
In the past year MBOT has reported a negative cash flow from operations.
In the past 5 years MBOT always reported negative net income.
MBOT had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
MBOT's Return On Assets of -215.15% is on the low side compared to the rest of the industry. MBOT is outperformed by 92.47% of its industry peers.
MBOT has a worse Return On Equity (-294.25%) than 81.72% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -215.15% | ||
| ROE | -294.25% | ||
| ROIC | N/A |
ROA(3y)-111.49%
ROA(5y)-77.78%
ROE(3y)-165.97%
ROE(5y)-111.73%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
MBOT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
MBOT has more shares outstanding than it did 1 year ago.
The number of shares outstanding for MBOT has been increased compared to 5 years ago.
There is no outstanding debt for MBOT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
MBOT has an Altman-Z score of -8.67. This is a bad value and indicates that MBOT is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -8.67, MBOT is not doing good in the industry: 77.42% of the companies in the same industry are doing better.
There is no outstanding debt for MBOT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -8.67 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
A Current Ratio of 3.64 indicates that MBOT has no problem at all paying its short term obligations.
With a decent Current ratio value of 3.64, MBOT is doing good in the industry, outperforming 66.67% of the companies in the same industry.
MBOT has a Quick Ratio of 3.64. This indicates that MBOT is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 3.64, MBOT is in the better half of the industry, outperforming 73.66% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.64 | ||
| Quick Ratio | 3.64 |
3. Growth
3.1 Past
MBOT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 42.28%, which is quite impressive.
EPS 1Y (TTM)42.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%4.76%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
The Earnings Per Share is expected to grow by 21.01% on average over the next years. This is a very strong growth
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y32%
EPS Next 2Y21.01%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for MBOT. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MBOT. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
MBOT's earnings are expected to grow with 21.01% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21.01%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for MBOT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
MICROBOT MEDICAL INC
NASDAQ:MBOT (1/7/2025, 8:00:01 PM)
Premarket: 2.43 -0.4 (-14.13%)2.83
-0.01 (-0.35%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners8.01%
Inst Owner Change0%
Ins Owners1.47%
Ins Owner Change0%
Market Cap47.91M
Analysts82.86
Price Target7.14 (152.3%)
Short Float %3.46%
Short Ratio2.01
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-6.69%
Min EPS beat(2)-15.34%
Max EPS beat(2)1.96%
EPS beat(4)3
Avg EPS beat(4)5.48%
Min EPS beat(4)-15.34%
Max EPS beat(4)33.33%
EPS beat(8)7
Avg EPS beat(8)12.07%
EPS beat(12)8
Avg EPS beat(12)3.96%
EPS beat(16)10
Avg EPS beat(16)2.73%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | N/A | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 12.58 | ||
| P/tB | 12.58 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.71
EYN/A
EPS(NY)-0.53
Fwd EYN/A
FCF(TTM)-0.53
FCFYN/A
OCF(TTM)-0.53
OCFYN/A
SpS0
BVpS0.22
TBVpS0.22
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -215.15% | ||
| ROE | -294.25% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-111.49%
ROA(5y)-77.78%
ROE(3y)-165.97%
ROE(5y)-111.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 10.89% | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.64 | ||
| Quick Ratio | 3.64 | ||
| Altman-Z | -8.67 |
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)66.21%
Cap/Depr(5y)120.44%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)42.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%4.76%
EPS Next Y32%
EPS Next 2Y21.01%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y5.41%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y25.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y25.15%
OCF growth 3YN/A
OCF growth 5YN/A